Loading the session
Loading the session
Loading instrument
$32.94
+1.48%DelayedDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 20:43 IST · A quote does not mean the product is available to trade on your account.
In brief
Questions investors ask
Quotes run fifteen minutes behind.
The 4 Nov 2026 gain of 7.6% was 6.0× its average daily move of 1.3% over the past year, and its largest one-day gain since 5 Aug 2025.
Daily closes, split-adjusted · as of 4 Nov 2026
The 4 Nov 2026 close of $32.46 was 14.3% above its 50-day average ($28.41) and 4.6% above its 200-day average ($31.04). It has closed above the 200-day for 1 session, since 4 Nov 2026. The 50-day average crossed below the 200-day on 10 Apr 2026, 144 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
1 month: +20.8% (SPY −1.6%). 3 months: +7.7% (SPY −0.4%). 1 year: −12.3% (SPY +13.6%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: SNN, SPY · as of 4 Nov 2026
The 14-session relative strength index closed at 74.5 on 4 Nov 2026, its 1st session at 70 or above. By convention a reading of 70 or above is called overbought and 30 or below oversold.
Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026
Closed at $32.46 on 4 Nov 2026: 12.5% below the 52-week high of $37.09 (27 Feb 2026) and 24.3% above the low of $26.12 (2 Oct 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
Price return, split-adjusted
At the 4 Nov 2026 close
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the US, just over 30% is from other developed markets, and emerging markets account for the remainder.
November 6, 2025
−11.72%August 5, 2025
+15.23%October 31, 2024
−13.03%